Martin Pölcher

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer

Philipp Harter, Jalid Sehouli, Annette Hasenburg et al. · International Journal of Gynecological Cancer · 2011 · 291 citations

Medicine, Oncology, Surgery +15

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 162 citations

Medicine, Gynecology, Oncology +14

Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma

Martin Pölcher, Michael Braun, Nicolaus Friedrichs et al. · Cancer Immunology Immunotherapy · 2010 · 84 citations · Full text

Medicine, Gynecology, Oncology +16

Targeted Activation of RNA Helicase Retinoic Acid–Inducible Gene-I Induces Proimmunogenic Apoptosis of Human Ovarian Cancer Cells

Kirsten Kübler, Nadine Gehrke, Soheila Riemann et al. · Cancer Research · 2010 · 80 citations · Full text

Life Sciences, Immunology, Oncology +17